Cure Logo
false

Partnered Events

AI-Driven Drug Discovery

Cure

AI Driven Drug Development

AI promises to bring more effective treatments to patients faster. Cure and The New York Academy of Sciences present a special Tuesday Talks with a panel of experts to discuss the transformative role of AI in developing new drugs for personalized medicine, rare diseases, and more. 

Introduction

Join us for an exploration of how startups are leveraging AI technology for the science and business of drug discovery and development. Cure, the healthcare innovation campus, and the New York Academy of Sciences, are hosting an event that gathers renowned experts like Grant Mitchell, MD, MBA, Co-Founder and CEO of Every Cure; Maria Luisa Pineda, PhD, Co-Founder and CEO of Envisagenics; and Andrea Califano, PhD, Chair, Department of Systems Biology at Columbia University and President of Chan Zuckerberg Biohub, who are using AI to bring speed, precision and accuracy to identifying new therapies. This event includes a networking reception.

Don't miss this opportunity to be part of the conversation! Secure your spot today. Space is limited!

Agenda

Tickets: In Person $20 NYAS Members/ $25 Non-members Virtual $15 Agenda: Opening Reception 4:30PM – 5:00 PM Programming 5:00 PM – 6:00 PM Closing Reception 6:00 – 6:30 PM

Recommended Event

The Science and Business of AI-Driven Drug Discovery

More about this topic

NYAS

Inspiring Hope, Not Fear: How AI is Already Transforming Drug Discovery

In the world of drug discovery, AI engenders feelings of hope, excitement and optimism. Indeed, machine learning algorithms already accelerate discovery, improve efficiency, reduce costs and even save lives.

ArticleJul 10, 2024